Ignite Creation Date:
2024-05-06 @ 2:20 AM
Last Modification Date:
2024-10-26 @ 11:16 AM
Study NCT ID:
NCT02013219
Status:
COMPLETED
Last Update Posted:
2020-04-21
First Post:
2013-12-11
Brief Title:
A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer NSCLC
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-04-03
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-02-05
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-11
First Submit QC Date:
December 16 2013
Study First Post Date:
2013-12-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-17
Last Update Post Date:
2020-04-21
Last Update Post Date Type:
ACTUAL